Final Results

Xaar PLC 13 March 2008 FOR IMMEDIATE RELEASE 13 March 2008 Xaar plc FINAL RESULTS FOR 2007 Xaar plc ('Xaar'), the inkjet printing technology group headquartered in Cambridge, announces its audited results for the year ended 31 December 2007. Key points: • The results reflect continued growth from Xaar's established, market leading printhead products. • The financial results for the year were: o Turnover was up 13% to £47.9m (2006: £42.2m); o Profit before tax increased 6% to £7.3m (2006: £6.9m) after providing for the early stage losses of the new Huntingdon manufacturing facility (2006: £nil); o Underlying profit before tax (before net Huntingdon costs) increased 35% to £9.3m (2006: £6.9m); o Earnings per share increased 9% to 8.6p (2006: 7.9p); and o Net cash at year end was £13.0m (2006: £12.4m) • 25% increase in proposed annual dividend to 2.5p (2006: 2.0p). • Good progress in commercialising new Platform 3 printhead products with a significant number of 'developer kits' sold to potential OEMs and initial printer product launches by Xaar customers. On outlook, Chairman, Phil Lawler stated: 'I believe that Xaar is well positioned to capitalise on the progressive shift from analogue to inkjet technology based printing - a trend which is gathering momentum within specialist and mainstream printing markets. 'Xaar's reputation and position in the inkjet market is building. We have the manufacturing capacity and capability, the technical knowledge and a committed and talented team which is now focused on execution and delivery of growth.' Contacts Xaar plc: today: 020-7367-8888 Ian Dinwoodie, Chief Executive thereafter: 01223-423663 Nigel Berry, Group Finance Director & Deputy Chief Executive www.xaar.com Andrew Taylor, Finance Director Designate Bankside Consultants: Steve Liebmann or Andy Harris 020-7367-8883 / 07802-888159 CHAIRMAN'S STATEMENT Introduction I am pleased to report a further year of progress, not just with results but also, significantly, with the level of interest in our Platform 3 product, the Xaar 1001. Xaar has reached an exciting stage in its development. Our main markets continued to grow during 2007 and our Platform 1 product range, now firmly established as market leader, is expected to continue to provide a solid foundation for the business going forward. At the same time, our new Platform 2 and Platform 3 products are beginning to enter the end user market as our OEM (Original Equipment Manufacturer) customers complete their development activities and launch new printing machines. These Platform 2 and Platform 3 products are more sophisticated than Platform 1 and appeal to printing machine manufacturers the world over (not just in Asia) in a wider range of applications. Consequently our potential market is now much larger. We believe, in line with independent industry analysts, that today less than 10% of commercial print world wide is produced using inkjet technology. Whilst the commercial printing market is conservative with long product life cycles, this benefits the longevity of our Platform 1 products. Our aim looking forward is to continue to accelerate the commercial adoption of our newer technologies. Results and dividend The results for the year were in line with IFRS compliant market consensus, showing growth in revenue and profits with a continued strong cash flow and sector leading performance at both the gross and net margin levels. While full details are provided within the financial review, it should be noted that the results are struck after providing for the early stage losses of the new Huntingdon plant - a long-term investment in manufacturing capacity for the new Platform 3 product range. Based on its confidence in the future profitability and cash generation of the business, the board has decided to recommend a 25% increase to 2.5p in the dividend per share for the year. With effect from 2008 it is the board's intention, subject to satisfactory performance, to introduce payment of an interim as well as a final dividend. Board 2007 has seen a number of changes to our board. In July Arie Rosenfeld retired as Chairman of the board. His deep knowledge and experience of our industry has been of great benefit to Xaar over the last ten years and we thank him sincerely for this. As stated in the Interim Report, founder and Technical Director Steve Temple retired but remains a consultant to the Company. We are pleased to keep Steve's counsel given his significant experience in inkjet and huge contribution to Xaar over many years. At that time we welcomed Ramon Borrell as Research and Development Director, having previously spent many years in senior roles at Hewlett-Packard's large format printing division. In October Greg Lockett joined the board as Manufacturing Director. Greg has been director of manufacturing at Xaar for the previous four years and this promotion reflects both his excellent work in that earlier role and his expected contribution in the future. In January 2008, Finance Director and Deputy Chief Executive Nigel Berry informed the company of his intention to resign from his position and from the board with effect from 31 March 2008. We thank him warmly for his excellent stewardship of the group's finances and relationships during the past six years during which the group has shown considerable development. We wish him every success for the future. Andrew Taylor, currently Deputy Finance Director and Company Secretary, will join the board as Finance Director on the same date. Andrew has been with the company since 2001 and we are pleased to have such an able replacement. Outlook I believe that Xaar is well positioned to capitalise on the progressive shift from analogue to inkjet technology based printing - a trend which is gathering momentum within specialist and mainstream printing markets. As a provider of printhead technology, I am confident that we have a world leading range of products that is attractive to our OEM customers as they develop new printers which are more functional, more efficient and more flexible. We have proof of this with the continuing success of the Platform 1 family of products which we expect to continue to provide a solid foundation for the group after more than a decade of commercial production, together with recent announcements of new OEM products incorporating our newer Platform 2 and 3 printheads. Xaar's reputation and position in the inkjet market is building. We have the manufacturing capacity and capability, the technical knowledge and a committed and talented team which is now focused on execution and delivery of growth. Phil Lawler Chairman 12 March 2008 REVIEW OF OPERATIONS Introduction I am pleased to report a solid set of results for 2007 as we continue to build Xaar's business and market presence. The existing core business, which serves the graphic display and product coding markets, continues to deliver robust returns whilst our new product developments are creating further opportunities in additional markets. These new products will complement the existing business and are expected to deliver continued growth over the medium term. Xaar is maintaining its level of investment in research and development with the intention of capturing a significant proportion of the digital printing market over the longer term. Business Review Xaar's business continues to consist of product sales, royalty income and development fees. Product sales proportionately dominate our revenue at 95% of the total, whilst royalty income has grown to 4% and development fees have fallen to 1% for the reasons described in the financial review. Sales of Platform 1 products, which serve the graphics display and product coding markets, increased during the year and continued to build their reputation as proven industrial solutions. This is especially true of the Xaar 128 which has become the 'de facto' standard printhead for these markets. The Platform 1 offerings are being enhanced regularly, including the successful launch of a new variant of the Xaar 126 product during 2007. The Xaar 126-35 enables high resolution printing for both solvent and UV ink applications based on this established small outline printhead. During the year a number of additional ink agreements for Platform 1 products were signed. These include the co-branding of locally manufactured inks for both the Chinese and Indian domestic markets. We also broadened our ink partnership arrangements for the international market with agreements concluded with both Fujifilm Sericol and Nazdar. During the year a new Platform 1 product has been developed, the Xaar 382; this high end product will complement the Xaar 128 by offering high resolution and high productivity performance for grand format printers. Concept samples of the product have been well received by existing customers and we expect to be supplying volume product during the second half of 2008. For both Platform 2 (Xaar 760) and Platform 3 (Xaar 1001) a significant amount of work has been undertaken with our partners to support their activities to bring their finished products to market. This process has taken longer than anticipated, especially for the Xaar 760. Whilst continuing to support our existing Platform 2 customers, we have encouraged a number of these development accounts to transfer from the 760 to 1001 to take advantage of the latest technology as both products are now available in volume. I am pleased to report that a significant number of developer kits for the Xaar 1001 have been shipped during the year, resulting in very positive feedback from both existing and new development partners. I am also particularly pleased to report that a number of digital printing products based on our latest technology have entered commercial life during the year. The first two models of commercial wide format printers were launched by Teckwin Development Co. Ltd. and have been well received by the market. Nilpeter, the world leader in analogue narrow web presses, announced its first digital product for the label market. Sales of this machine, named 'Caslon', will commence during 2008. Additionally EFI, the large US printing technology group has launched a digital narrow web label press based on the Xaar 1001. The EFI Jetrion 4000 press commenced limited shipments at the end of 2007 and will be available in volume from the second quarter 2008. Further launches are expected during the year, particularly at or around 'Drupa', the world's largest print and imaging trade show held in late May every four years in Dusseldorf, Germany. Whilst the timescale to generate returns from these new products has been frustratingly long, we remain confident that the value generated from these developments will significantly enhance the financial performance of the company over time. Commercial Review - Geographic As a supplier of technology to OEM partners, our geographic sales split will reflect where the OEM equipment is manufactured - not necessarily the end user location. As the largest centre for manufacturing, Asia continues to be our most important market, generating 58% of total sales in 2007 and growing 17% over last year. Within the Asian region China remains our largest sales country and this market has continued to develop, both at the OEM and end user level; we continue to establish new relationships in this dynamic market. I would also highlight the success of our Indian sales operation during the year. Opened in late 2004, sales take-up was slower than initially expected, but over the past year we have started to see the benefits of our investment in the area with a substantial increase in sales. Europe and the Middle East remains our second largest sales area. Sales into this region were £14.2m being 30% of worldwide revenue. Sales were down 5% on 2006 following a poor first half which was commented on in the Interim Report. As stated at that time, no significant changes have occurred in the European market and this result is the net effect of certain 'ups' and 'downs' across multiple accounts, together with the reduction in development fees from Agfa as referred to in the financial review. Sales to the Americas region showed excellent growth, increasing 74% over 2006 levels. Sales in the period totalled £5.7m, this being 12% of the group total. This growth came principally from South America where we opened a sales operation in 2005. Mirroring our experience in India, sales initially were modest whilst a local OEM base was established. During 2007 we began to see the benefits of this early groundwork with a substantial increase in the level of business. Over time we would expect to see continued growth in all regions, with Western markets leading the way initially with the adoption of our newer technologies. Commercial Review - End Markets The graphic arts market continues to be the primary end use of Xaar technology and, specifically, in the segment of large format advertising. 73% of sales were related to this market totalling £34.9m (2006: £31.3m), where industrial inkjet continues to displace screen printing as the most economic and flexible process for both interior and outdoor large format advertising. The new Xaar 382 product is expected to consolidate our leading market share in this application. The packaging market continues to grow for Xaar, albeit our sales in this sector are presently still dominated by product coding applications. Revenues of £9.0m in 2007 represent a 19% increase over 2006; this market represents almost one fifth of our business. While product coding is a small segment of the overall packaging print market, we expect to see significant growth in revenues over the next few years from this packaging sector starting with digital label printing, followed by wider aspects of primary packaging. The Xaar 1001 product is our 'entry vehicle' into this market and we are pleased to see the Xaar 1001 based Nilpeter Caslon and EFI Jetrion 4000 products already being offered in this market. As noted in the Interim Report, whilst there are many potential opportunities for inkjet to become adopted in non-print related areas, the commercial returns are on a longer timeline. Accordingly we have redirected our business development activities toward an acceleration of our entry into the labelling and packaging print markets noted above. However, in the non-printing industrial space we continue to support a set of developers exploring many possibilities including applications such as flat panel displays, flexible electronics and 3D material deposition, to ensure that when real commercial opportunities present themselves Xaar is well positioned to take advantage. Sales into this industrial market for the year amounted to £1.7m, a 52% increase albeit from a small base, and representing 4% of total sales. Operations Review Following the successful commissioning of the Huntingdon plant in 2006, production of Platform 3 Xaar 1001 products started on schedule in January 2007. The facility has supported numerous partner developments all over the world with developer kits and initial production volumes. The availability of supply of fully functional leading technology is critical to our partners' development programmes and the Huntingdon operation has performed this role superbly throughout the year. From this excellent start we now need to support our partners' commercial implementations which will, in turn, generate the volume demand which will bring the plant into profitability. The Jarfalla plant in Sweden continued to perform well throughout the year, supplying the bulk of product sales for the year. Investment in R&D continued at its planned level of £4.8m, representing 10% of sales. This has supported the development of new products, enhancements to existing products and the investment in future technologies. This ongoing investment will ensure Xaar has a well primed pipeline of new product offerings, targeted at accelerating the growth potential of the company. Priorities for the Future The top priority for 2008 is to accelerate the generation of commercial returns from our new products which we have seeded into the market over the last year. The Xaar 1001 is a key breakthrough in inkjet technology performance - especially in terms of reliability and ease of use; we believe this product is a major enabling tool to open new business opportunities for Xaar. We look forward to 2008 with confidence based on our established profitable business and the opportunities in additional markets from our new products. People I would like to thank all our staff worldwide whose efforts, skill and dedication are critical to the successful future of our business. Ian Dinwoodie Chief Executive 12 March 2008 FINANCIAL REVIEW Trading Revenues in the second six months of 2007 were £24.4m (2006: £19.9m), an increase of 23% over the same period last year and 4% over the first half of 2007. Revenues for the full year increased 13% over 2006 to £47.9m (2006: £42.2m). Product sales account for 95% of revenues (2006: 95%) with sales of Platform 1 products continuing to grow and to dominate the sales figures. Looking forward, we expect our strategic partners to begin soon introducing products based on Platform 2 and Platform 3 printheads and for these products to generate an increasing proportion of our revenues in 2008 and beyond. Licensee royalties grew 15% to £1.8m (2006: £1.5m) representing 4% of revenue and we expect this growth to continue in the future. Development fees fell to £0.5m (2006: £0.8m) due to the completion of the major part of our co-development programme with Agfa. We expect development fees to be at a similar level for 2008 and 2009 but to reduce thereafter. The gross margin for the year was 52% (2006: 57%), reflecting the fixed costs of the Huntingdon facility which were in line with previous guidance at £2.5m for the year (2006: £nil). Gross margin excluding the net impact of the Huntingdon facility was 58%, an improvement of 1% over the prior year. As production volumes at the plant increase we expect its profitability to match that of our manufacturing facility in Sweden. Headline operating costs for the year increased only slightly to £17.9m (2006: £17.5m) and include the IFRS (non-cash) charges for share option costs of £1.0m (2006: £0.7m) and amortisation of capitalised R&D of £1.0m (2006: £0.5m). On a like for like cash basis the company reduced its operating costs by £0.4m during the year. Over the last two years we have developed and successfully launched our second and third platforms of products and, as required under IFRS, have capitalised the internal development costs associated with those platforms. For the future it is expected that internal R&D costs will relate mostly to improvements to existing product platforms and, as such, will not be capitalised. Amortisation of previously capitalised internal R&D costs is already underway and is expected to complete in 2011. On a fully IFRS compliant basis, profit before tax for the year grew 6% to £7.3m (2006: £6.9m) with basic earnings per share of 8.6p (2006: 7.9p). Excluding the net impact of Huntingdon, profit before tax would have been £9.3m, an increase of 35% over 2006. Dividend The directors are recommending an increase in the dividend of 25% to 2.5p per share (2006: 2.0p). The dividend will be covered 3.4 times. In addition, and subject to satisfactory performance, it is the intention for 2008 to introduce an interim dividend payment. This reflects the board's confidence in future profit and cash generation. Foreign currency A majority of the group's revenues in the year (72%) were invoiced in sterling (2006: 47%), with 22% invoiced in US dollars (2006: 47%). This reflects the full year effect of our decision in mid 2006 to move most of our Chinese customers from US dollar to sterling trading terms. The group continues to have an exposure to the Swedish kronor through its requirement to fund its operations in Sweden and manages this exposure using forward currency contracts. Cash and capital expenditure Cash at the end of the year was £13.0m (2006: £12.4m) and is stated after the payment of dividends of £1.2m (2006: £0.9m) and capital expenditure of £5.7m (2006: £11.1m). With the final stage payments on capital equipment for the Huntingdon facility having been made in early 2007, capital expenditure in 2008 and 2009 is expected to be lower than the current year. Change of Director After nearly six years as Finance Director I shall be leaving the company at the end of March 2008 and would like to wish the company, its shareholders and staff every success for the future. I am pleased to say that my deputy, Andrew Taylor, will succeed me as Finance Director and I offer him my congratulations on his appointment. Nigel Berry Finance Director 12 March 2008 Consolidated income statement for the year ended 31 December 2007 2007 2006 Notes £'000 £'000 ------------------------------ ------ -------- --------- Continuing operations Revenue 2 47,853 42,207 Cost of sales (22,925) (18,096) ------------------------------ ------ -------- --------- Gross profit 24,928 24,111 Distribution costs (4,003) (4,108) Administrative expenses (13,932) (13,426) ------------------------------ ------ -------- --------- Operating profit 6,993 6,577 Investment income 447 451 Finance costs (119) (116) ------------------------------ ------ -------- --------- Profit before tax before abortive deal costs and share-based payments 8,275 7,921 Abortive deal costs - (298) Share-based payments (954) (711) ------------------------------ ------ -------- --------- Profit before tax 7,321 6,912 Tax (1,920) (2,068) ------------------------------ ------ -------- --------- Profit for the year attributable to shareholders 5,401 4,844 Earnings per share from continuing operations Basic 3 8.6p 7.9p Diluted 3 8.4p 7.6p ------------------------------ ------ -------- --------- Dividends paid in the year amounted to £1,218,000 (2006: £903,000). Consolidated statement of recognised income and expense for the year ended 31 December 2007 2007 2006 £'000 £'000 ---------------------------------- --------- --------- Exchange differences on translation of foreign operations (64) (113) Cash flow hedges transferred to income statement - 1,197 Tax on items taken directly to equity (746) (415) ---------------------------------- --------- --------- Net (loss)/income recognised directly in equity (810) 669 Profit for the year 5,401 4,844 ---------------------------------- --------- --------- Total recognised income and expense for the year 4,591 5,513 ---------------------------------- --------- --------- Consolidated balance sheet as at 31 December 2007 2007 2006 £'000 £'000 --------------------------------- --------- ---------- Non-current assets Property, plant and equipment 11,849 11,990 Goodwill 720 720 Other intangible assets 7,294 7,030 Investments 2,020 1,931 Deferred tax asset 322 1,383 --------------------------------- --------- ---------- 22,205 23,054 --------------------------------- --------- ---------- Current assets Inventories 4,137 3,690 Trade and other receivables 8,511 6,135 Cash and cash equivalents 13,036 12,438 Derivative financial instruments 261 - --------------------------------- --------- ---------- 25,945 22,263 --------------------------------- --------- ---------- Total assets 48,150 45,317 --------------------------------- --------- ---------- Current liabilities Trade and other payables (6,711) (7,928) Other financial liabilities (198) (185) Current tax liabilities (1,246) (507) Obligations under finance leases (245) (468) Provisions (193) (209) --------------------------------- --------- ---------- (8,593) (9,297) --------------------------------- --------- ---------- Net current assets 17,352 12,966 Non-current liabilities Deferred tax liabilities (1,810) (1,635) Other financial liabilities (651) (865) Obligations under finance leases - (267) --------------------------------- --------- ---------- (2,461) (2,767) --------------------------------- --------- ---------- Total liabilities (11,054) (12,064) --------------------------------- --------- ---------- Net assets 37,096 33,253 --------------------------------- --------- ---------- Equity Share capital 6,285 6,201 Share premium 10,146 9,669 Own shares (4,465) (3,420) Other reserves 4,051 3,097 Translation reserve 529 593 Retained earnings 20,550 17,113 --------------------------------- --------- ---------- Equity attributable to shareholders 37,096 33,253 --------------------------------- --------- ---------- Total equity 37,096 33,253 --------------------------------- --------- ---------- Consolidated cash flow statement for the year ended 31 December 2007 2007 2006 Note £'000 £'000 ------------------------------- ------ ---------- ---------- Net cash from operating activities 4 8,565 9,142 Investing activities Purchases of property, plant and equipment (3,823) (7,274) Proceeds on disposal of property, plant and - 5 equipment Purchases of trading investments (89) (427) Expenditure on capitalised product development (1,770) (3,420) ------------------------------- ------ ---------- ---------- Net cash used in investing activities (5,682) (11,116) Financing activities Dividends paid (1,218) (903) Proceeds from issue of ordinary share capital 561 384 New borrowings - 1,050 Repayments of borrowings (201) - Repayments of obligations under finance leases (498) (520) Purchase of own shares (1,045) - ------------------------------- ------ ---------- ---------- Net cash (outflow)/inflow from financing (2,401) 11 activities ------ ---------- ---------- ------------------------------- Net increase/(decrease) in cash and cash 482 (1,963) equivalents Effect of foreign exchange rate changes 116 6 Cash and cash equivalents at beginning of year 12,438 14,395 ------------------------------- ------ ---------- ---------- Cash and cash equivalents at end of year 13,036 12,438 ------------------------------- ------ ---------- ---------- Notes to the consolidated financial statements for the year ended 31 December 2007 1.Basis of preparation Information in this final announcement does not constitute statutory accounts of the group within the meaning of Section 240 of the Companies Act 1985. The financial information for the year ended 31 December 2007 and the year ended 31 December 2006, presented in this final announcement is extracted from, and is consistent with, that in the group's audited financial statements for the year ended 31 December 2007. The financial statements were approved by the board of directors on 12 March 2008; the auditor's report on these accounts was unqualified. The financial statements will be delivered to the Registrar of Companies following the company's Annual General Meeting. Statutory accounts for the year ended 31 December 2006, which were prepared under International Financial Reporting Standards, have been filed with the Registrar of Companies. The auditor's report on those accounts was unqualified and did not contain any statement under Section 237 of the Companies Act 1985. 2. Business and geographical segments Revenue An analysis of the group's revenue is as follows: 2007 2006 £'000 £'000 --------------------------------- --------- ---------- Sales of goods 45,612 39,918 Development fees 467 748 Licence fees and royalties 1,774 1,541 ---------------------------------- --------- -------- 47,853 42,207 Investment income 447 451 ---------------------------------- --------- -------- 48,300 42,658 --------------------------------- --------- --------- Business segments For management reporting purposes, the group's operations are currently analysed according to product type. These product groups are the basis on which the group reports its primary segment information. Principal product groups are as follows: • Printheads and related products • Development fees • Licence fees and royalties Segment information about these product types is presented below. 2007 2006 £'000 £'000 ---------------------------------- --------- -------- Revenue Printheads and related products 45,612 39,918 Development fees 467 748 Licence fees and royalties 1,774 1,541 ---------------------------------- --------- -------- Total revenue 47,853 42,207 ---------------------------------- --------- -------- 2. Business and geographical segments (continued) Business segments (continued) 2007 2006 £'000 £'000 ---------------------------------- --------- -------- Result Printheads and related products 17,025 16,198 Development fees (79) (442) Licence fees and royalties 1,415 1,247 ---------------------------------- --------- -------- Total segment results 18,361 17,003 Unallocated corporate expenses (11,368) (10,426) ---------------------------------- --------- -------- Profit from operations 6,993 6,577 Investment income 447 451 Finance costs (119) (116) ---------------------------------- --------- -------- Profit before tax 7,321 6,912 Tax (1,920) (2,068) ---------------------------------- --------- -------- Profit after tax 5,401 4,844 ---------------------------------- --------- -------- Unallocated corporate expenses relate to administrative expenses which cannot be directly attributed to any of the principal product groups. Other information Printheads Licence and related Development fees and products fees royalties Consolidated 2007 2007 2007 2007 £'000 £'000 £'000 £'000 ------------------ ---------- ---------- --------- ---------- Capital additions 3,693 - - 3,693 Depreciation and amortisation 2,958 463 58 3,479 ------------------ ---------- ---------- --------- ---------- Balance sheet Assets Segment assets 28,045 913 594 29,552 Unallocated corporate assets 18,598 ------------------ ---------- ---------- --------- ---------- Consolidated total assets 48,150 ------------------ ---------- ---------- --------- ---------- Liabilities Segment liabilities (4,886) (782) (89) (5,757) Unallocated corporate (5,297) liabilities ---------- ---------- --------- ---------- ------------------ Consolidated total (11,054) liabilities ---------- ---------- --------- ---------- ------------------ Printheads Licence and related Development fees and products fees royalties Consolidated 2006 2006 2006 2006 £'000 £'000 £'000 £'000 ----------------- ---------- ---------- --------- ---------- Capital additions 11,147 - - 11,147 Depreciation and amortisation 1,531 616 59 2,206 ----------------- ---------- ---------- --------- ---------- Balance sheet Assets Segment assets 24,440 1,378 635 26,453 Unallocated corporate assets 18,864 ----------------- ---------- ---------- --------- ---------- Consolidated total assets 45,317 ----------------- ---------- ---------- --------- ---------- Liabilities Segment liabilities (5,781) (1,162) (82) (7,025) Unallocated corporate (5,039) liabilities ---------- ---------- --------- ---------- ----------------- Consolidated total (12,064) liabilities ---------- ---------- --------- ---------- ----------------- Unallocated corporate assets include £594,000 (2006: £449,000) of capital additions, and are net of depreciation and amortisation for the year of £743,000 (2006: £577,000). 2. Business and geographical segments (continued) Geographical segments The group's operations are located in Asia, Europe and North and South America. The following table provides an analysis of the group's sales by geographical market, which is considered to be the group's secondary segment, irrespective of the origin of the goods: 2007 2006 £'000 £'000 ----------------- ---------- ---------- --------- ---------- Asia 27,937 23,937 Europe and Middle East 14,235 14,997 Americas 5,681 3,273 ----------------- ---------- ---------- --------- ---------- 47,853 42,207 ----------------- ---------- ---------- --------- ---------- Substantially, all assets and additions to property, plant and equipment and intangible assets are located in Europe and the Middle East. 3. Earnings per ordinary share - basic and diluted The calculation of basic and diluted earnings per share is based on the following data: 2007 2006 £'000 £'000 ----------------------------------- --------- -------- Earnings Earnings for the purposes of basic earnings per share being net profit attributable to equity holders of the parent 5,401 4,844 ----------------------------------- --------- -------- Number of shares Weighted average number of ordinary shares for the purposes of basic earnings per share 62,514,226 61,447,492 Effect of dilutive potential ordinary shares: Share options 1,599,424 2,221,595 ---------------------------------- --------- --------- Weighted average number of ordinary shares for the purposes of diluted earnings per share 64,113,650 63,669,087 ---------------------------------- --------- --------- 4 Notes to the cash flow statement 2007 2006 £'000 £'000 ----------------------------------- --------- --------- Profit before tax 7,321 6,912 Adjustments for: Share-based payments 954 711 Depreciation of property, plant and equipment 2,895 1,998 Amortisation of intangible assets 1,320 785 Loss on disposal of property, plant and equipment 12 15 (Decrease)/increase in provisions (16) 89 ----------------------------------- --------- --------- Operating cash flows before movements in working capital 12,486 10,510 Increase in inventories (319) (814) (Increase)/decrease in receivables (2,645) 1,944 (Decrease)/increase in payables (16) 78 ----------------------------------- --------- --------- Cash generated by operations 9,506 11,718 Income taxes paid (941) (2,576) ----------------------------------- --------- --------- Net cash from operating activities 8,565 9,142 ----------------------------------- --------- --------- Cash and cash equivalents (which are presented as a single class of asset on the face of the balance sheet) comprise cash at bank and other short term highly liquid investments with a maturity of three months or less. This information is provided by RNS The company news service from the London Stock Exchange

Companies

Xaar (XAR)
UK 100

Latest directors dealings